Blog
RSS FeedPosted by Michael Wonder on 21 Mar 2025
Why US drug giants are so angry about Australia’s PBS
20 March 2025 - US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays ...
Posted by Michael Wonder on 20 Mar 2025
Australia defends PBS as US companies urge Trump to impose reciprocal tariffs
19 March 2025 - American medical giants have labelled the federal government's PBS "egregious and discriminatory" and have pressed US ...
Posted by Michael Wonder on 20 Mar 2025
Big pharma’s plea to Trump to punish Australia for cheaper medicines
19 March 2025 - American medical giants have slammed the $18 billion pharmaceutical benefits scheme in a plea to US ...
Posted by Michael Wonder on 20 Dec 2024
ICER publishes fourth annual assessment of barriers to fair access within US commercial insurance prescription drug coverage
19 December 2024 - Most payers evaluated offer fair access across the domains reviewed; findings underscore the need for greater ...
Posted by Michael Wonder on 20 Dec 2024
New agreement to ensure medicines stay cheaper and on pharmacy shelves
19 December 2024 - The Australian Government is ensuring medicines stay cheaper and on pharmacy shelves across Australia, through a new ...
Posted by Michael Wonder on 12 Dec 2024
ICER announces most significant drug price hikes unsupported by new clinical evidence in US
12 December 2024 - Of 10 high expenditure drugs that had substantial 2023 net price increases, five were not supported ...
Posted by Michael Wonder on 22 Sep 2024
Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines
18 September 2024 - Amid debate over potential abuse of the US patent system by the pharmaceutical industry, moves by ...
Posted by Michael Wonder on 28 May 2024
David Seymour’s special envoy in medicines is dumping his drug company investments
28 May 2024 - Act MP Todd Stephenson is selling his investments in drug companies while labelling as “outrageous” claims ...
Posted by Michael Wonder on 05 Feb 2024
Be thankful for high drug prices
4 February 2024 - If Americans weren’t overcharged, we wouldn’t have innovative treatments. ...
Posted by Michael Wonder on 29 Jan 2024
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
26 January 2024 - Bristol Myers Squibb CEO Chris Boerner and another unnamed pharmaceutical CEO accepted initial invitations to testify. ...
Posted by Michael Wonder on 22 Jan 2024
Generic drugs in the US are too cheap to be sustainable, experts say
19 January 2024 - Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of ...
Posted by Michael Wonder on 18 Jan 2024
Drug makers raise prices of Ozempic, Mounjaro and hundreds of other drugs
18 January 2024 - Companies hiked prices of 775 brand name drugs at start of new year. ...
Posted by Michael Wonder on 03 Jan 2024
Drug makers set to raise US prices on at least 500 drugs in January
29 December 2023 - Drug makers including Pfizer, Sanofi and Takeda plan to raise prices in the United States on ...
Posted by Michael Wonder on 11 Dec 2023
ICER identifies most significant 2022 US drug price hikes unsupported by new clinical evidence
11 December 2023 - Of 10 high expenditure drugs that had substantial 2022 net price increases, eight were not supported by ...
Posted by Michael Wonder on 06 Dec 2023
Reimbursement to pharmacies for generic drugs by Medicare Part D sponsors
5 December 2023 - Pharmacy benefit managers (PBMs) manage prescription drug benefits on behalf of health insurers; PBMs negotiate reimbursements for ...